Persistent negative symptoms in young people at clinical high risk of psychosis treated with an Italian early intervention program: a longitudinal study Camilla RicciEmanuela LeuciLorenzo Pelizza Original Paper Open access 26 April 2024
Ketamine and its enantiomers for depression: a bibliometric analysis from 2000 to 2023 Li-yuan ZhaoGuang-fen ZhangJian-jun Yang Original Paper 25 April 2024
Altered patterns of dynamic functional connectivity of brain networks in deficit and non-deficit schizophrenia Biying YeYiqiao WuXiangrong Zhang Original Paper 25 April 2024
Bright light therapy versus physical exercise to prevent co-occurring depression in adolescents and young adults with attention-deficit/hyperactivity disorder: a multicentre, three-arm, randomised controlled, pilot phase-IIa trial Jutta S. MayerLaura KohlhasChristine M. Freitag Original Paper Open access 16 April 2024
Cognitive horizons in chronic pain: unraveling neuroscientific insights and innovative interventions for fibromyalgia Jie SunXiaoxing LiuLin Lu Editorial 15 April 2024
The boon and bane of nitrous oxide Golo KronenbergGeorgios SchoretsanitisSebastian Olbrich Invited Review Open access 13 April 2024
Criminal behavior in alcohol-related dementia and Wernicke–Korsakoff syndrome: a Nationwide Register Study Anniina PalmTiina TalaslahtiHannu Koponen Original Paper Open access 13 April 2024
Beneficial and adverse effects of ketamine and its enantiomers, and the underlying mechanisms of ECT and rTMS efficacy Kenji Hashimoto Editorial 12 April 2024
Diminished differentiation of rewards in individuals at clinical high-risk for psychosis D. N. PrattM. T. TreadwayV. A. Mittal Original Paper 10 April 2024
Genetic predisposition for negative affect predicts mental health burden during the COVID-19 pandemic Alicia M. SchoweMalvika GodaraElisabeth B. Binder Original Paper Open access 08 April 2024
Effects of an integrative multimodal inpatient program on fatigue and work ability in patients with Post-COVID Syndrome—a prospective observational study Sarah SchmidChristine UeckerJost Langhorst Original Paper 05 April 2024
Change in brain activation after transcranial pulsed electromagnetic fields in treatment-resistant depression Sjoerd M. van BelkumEsther M. OpmeerAndré Aleman Original Paper Open access 05 April 2024
Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trial Siegfried KasperHans-Peter VolzErich Seifritz Original Paper Open access 01 April 2024
Sex differences in anhedonia in bipolar depression: a resting-state fMRI study Xiaoqin WangYi XiaQing Lu Original Paper 01 April 2024
Stacked artificial neural network to predict the mental illness during the COVID-19 pandemic Usharani Bhimavarapu Original Paper 01 April 2024
Exposure to psychotropic drugs and breast cancer risk in patients with bipolar disorder and major depressive disorder: a nested case–control study Dian-Jeng LiShih-Jen TsaiMu-Hong Chen Original Paper Open access 30 March 2024
Comparing the latent state–trait structure of the PANSS in cariprazine-medicated and placebo-controlled patients with acute schizophrenia Jana S. KrücklKároly AcsaiChristian G. Huber Original Paper Open access 29 March 2024
Predictors of adherence to exercise interventions in people with schizophrenia Rebecca SchwaigerIsabel MaurusLukas Roell Original Paper Open access 29 March 2024
Interaction between baseline BMI and baseline disease severity predicts greater improvement in negative symptoms in first-episode schizophrenia Xiaobing SunRuiqing HeXiang Yang Zhang Original Paper 27 March 2024
Childhood abuse and craving in methamphetamine-dependent individuals: the mediating role of alexithymia Jiajing ChenDong Mei WangXiang Yang Zhang Original Paper 26 March 2024
From pathogenesis of stress-related mental disorders to treatment: beyond the brain Xiaoxing LiuLin Lu Editorial 22 March 2024 Pages: 473 - 474
Deciphering the interplay between psychopathological symptoms, sensorimotor, cognitive and global functioning: a transdiagnostic network analysis Stefan FritzeGeva A. BrandtDusan Hirjak Original Paper Open access 20 March 2024
Does cannabis use substitute for opioids? A preliminary exploratory survey in opioid maintenance patients Nina Kim BekierUlrich FrischknechtDerik Hermann Original Paper 19 March 2024
Endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication Natalia Mansur HaddadLeonardo Peroni De JesusAlexandre Andrade Loch Original Paper 19 March 2024
Post-COVID breathlessness: a mathematical model of respiratory processing in the brain Dina von WerderFranziska RegnathStefan Glasauer Original Paper Open access 19 March 2024
The impact of aerobic endurance training on cognitive performance in schizophrenic inpatients in a clinical routine setting Elisa SemlerFlorian HerpichAlexander Brunnauer Original Paper 19 March 2024
Cannabis use, health problems, and criminal offences in Germany: national and state-level trends between 2009 and 2021 Jakob MantheySinja KlingerLarissa Schwarzkopf Original Paper Open access 19 March 2024
Evolution of the profiles of new psychotropic drug users before and during the COVID-19 crisis: an original longitudinal approach through multichannel sequence analysis using the French health-care database Marion IstvanMélanie DuvalCaroline Victorri-Vigneau Original Paper 18 March 2024
Proinflammatory cytokine levels, cognitive function, and suicidal symptoms of adolescents and young adults with major depressive disorder Mu-Hong ChenYa-Mei BaiShih-Jen Tsai Original Paper Open access 16 March 2024
Predictors of effective therapy among individuals with Cannabis Use Disorder: a review of the literature Daniel FeingoldDana Tzur BitanEva Hoch Original Paper 16 March 2024
Association between psychiatric admissions in patients with schizophrenia and IL-6 plasma levels polygenic score Fernando FacalManuel ArrojoJavier Costas Original Paper 16 March 2024
Cannabis use and cannabis use disorders and their treatment in the Europe Wayne HallJakob MantheyDaniel Stjepanović Original Paper Open access 15 March 2024
Prevalence and associated factors of obesity in patients with major depressive disorder at different ages of onset Xiaoen LiuXue TianXiangyang Zhang Original Paper 15 March 2024
The curious absence of psychosis in GRIN1-related neurodevelopmental disorder Mark A. ColijnRobert M. Stowe Letter to the Editor 14 March 2024
The impact of the COVID-19 pandemic on perceptions of social relationships, negative affect, and paranoid ideation Ryan D. OrthChristina L. G. SavageJack J. Blanchard Original Paper 13 March 2024
Association of empathy with clinical symptoms and cognitive function in chronic schizophrenia patients with and without suicide attempts Zheng MaYang TianXiang-Yang Zhang Original Paper 13 March 2024
Borderline personality disorder vs. schizophrenia spectrum disorders in young people recruited within an “Early Intervention in Psychosis” service: clinical and outcome comparisons Lorenzo PelizzaEmanuela LeuciMarco Menchetti Original Paper Open access 12 March 2024
Correlative relationship between body mass index and heart rate variability in psychiatric disorders WenZheng WangLinLin ZhouTianHong Zhang Original Paper 12 March 2024
The neurobiological effects of childhood maltreatment on brain structure, function, and attachment Akemi TomodaShota NishitaniMartin H. Teicher Invited Review Open access 11 March 2024
Demographic, biochemical, clinical, and cognitive symptom differences between smokers and non-smokers in Chinese older male patients with chronic schizophrenia Wei LiLing YueShifu Xiao Original Paper Open access 10 March 2024
Polypharmacy in psychiatry and weight gain: longitudinal study of 832 patients hospitalized for depression or schizophrenia, along with data of 3180 students from Europe, the U.S., South America, and China H. H. StassenS. BachmannE. Seifritz Original Paper Open access 10 March 2024
Pathways to professional mental care in the Swiss young adult community: a case–control study N. OsmanC. MichelF. Schultze-Lutter Original Paper Open access 01 March 2024
The prevalence of poor sleep quality in the general population in China: a meta-analysis of epidemiological studies Pan ChenMei Ieng LamYu-Tao Xiang Original Paper 01 March 2024
Are thoughts and behaviours of individuals with schizophrenia more susceptible to being influenced during pandemic situations? A glimpse provided by the COVID-19 pandemic Erica FongaroRoyce AndersStephane Raffard Short Communication 29 February 2024
White matter brain age as a biomarker of cerebrovascular burden in the ageing brain Jing DuYuangang PanWei Wen Original Paper Open access 29 February 2024
Dampened motivation in schizophrenia: evidence from a novel effort-based decision-making task in social scenarios Yu-Xin ShaoLing-Ling WangChao Yan Original Paper 28 February 2024
Serotonin deficiency and psychiatric long COVID: both caused specifically by the virus itself or an adaptive general stress response? Udo BonnetJens Kuhn Letter to the Editor 27 February 2024
Are “mystical experiences” essential for antidepressant actions of ketamine and the classic psychedelics? Kenji Hashimoto Invited Review Open access 27 February 2024
Interactions between overweight/obesity and alcohol dependence impact human brain white matter microstructure: evidence from DTI Hai-Ling CaoWei WeiWan-Jun Guo Original Paper 26 February 2024
Neurocognitive function as outcome and predictor for prefrontal transcranial direct current stimulation in major depressive disorder: an analysis from the DepressionDC trial Aldo SoldiniUlrike VogelmannGerrit Burkhardt Original Paper Open access 26 February 2024
